Influenza A/ equi- 2/ Ohio/ 03 [H3N8] rekombinant canarypox virus (vCP2242) ≥ 5, 3 log10 FAID* 50 Influenza A/ equi- 2/ Newmarket/ 2/ 93 [H3N8] rekombinant canarypox virus (vCP1533) ≥ 5, 3 log10 FAID* 50 * "fluorescent assay" infektiøs dosis 50% Clostridium tetani toxoid ……………………………………………………………………. > 30 IU ** ** antitoksisk antistoftiter induceret efter gentagen vaccination i marsvinesera i henhold til Ph.
Influenza A/ equi- 2/ Ohio/ 03 [H3N8] rekombinantne Canarypox viirus (vCP2242).................................................................................................................................. ≥ 5. 3 log10 FAID* 50 Influenza A/ equi- 2/ Newmarket/ 2/ 93 [H3N8] rekombinantne Canarypox viirus (vCP1533).................................................................................................................................. ≥ 5. 3 log10 FAID* 50 * Fluoressentstesti infitseeriv doos 50% Clostridium tetani toksoid …………………………………………………………………. ≥30 RTÜ ** ** antitoksiliste antikehade tiiter, mis tekib merisigade seerumis peale korduvat vaktsineerimist vastavalt Ph.